{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:05:26Z","timestamp":1784696726533,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"DOI":"10.1007\/s00247-025-06390-4","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T08:10:38Z","timestamp":1757664638000},"page":"2800-2812","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of phase-resolved functional lung (PREFUL) and hyperpolarized 129Xe MRI for longitudinal monitoring of lung function in pediatric cystic fibrosis following elexacaftor\/tezacaftor\/ivacaftor"],"prefix":"10.1007","volume":"55","author":[{"given":"Samal","family":"Munidasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiyza","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Zanette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wallace","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Braganza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Ratjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles","family":"Santyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"6390_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrg3849","volume":"16","author":"GR Cutting","year":"2014","unstructured":"Cutting GR (2014) Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet 16:45\u201356","journal-title":"Nat Rev Genet"},{"key":"6390_CR2","first-page":"7","volume":"26","author":"K Harman","year":"2017","unstructured":"Harman K, Dobra R, Davies JC (2017) Disease-modifying drug therapy in cystic fibrosis. Paediatr Respir Rev 26:7\u20139","journal-title":"Paediatr Respir Rev"},{"key":"6390_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1164\/rccm.202008-3176LE","volume":"203","author":"M Griese","year":"2021","unstructured":"Griese M, Costa S, Linnemann RW et al (2021) Safety and efficacy of elexacaftor\/tezacaftor\/ivacaftor for 24 weeks or longer in people with cystic fibrosis and one or more F508del alleles: interim results of an open-label phase 3 clinical trial. Am J Respir Crit Care Med 203:381\u2013385","journal-title":"Am J Respir Crit Care Med"},{"key":"6390_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1056\/NEJMoa2100665","volume":"385","author":"PJ Barry","year":"2021","unstructured":"Barry PJ, Mall MA, \u00c1lvarez A et al (2021) Triple therapy for cystic fibrosis Phe508del-gating and -residual function genotypes. N Engl J Med 385:815\u2013825","journal-title":"N Engl J Med"},{"key":"6390_CR5","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202404-396OC","volume-title":"Longitudinal magnetic resonance imaging of changes in lung morphology and perfusion in children with cystic fibrosis from infancy through adolescence","author":"MO Wielp\u00fctz","year":"2024","unstructured":"Wielp\u00fctz MO, Stahl M, Triphan SMF et al (2024) Longitudinal magnetic resonance imaging of changes in lung morphology and perfusion in children with cystic fibrosis from infancy through adolescence. Published online, Ann Am Thorac Soc. https:\/\/doi.org\/10.1513\/AnnalsATS.202404-396OC"},{"key":"6390_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1164\/rccm.202201-0219OC","volume":"206","author":"SY Graeber","year":"2022","unstructured":"Graeber SY, Renz DM, Stahl M et al (2022) Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on lung clearance index and magnetic resonance imaging in patients with cystic fibrosis and one or two F508del alleles. Am J Respir Crit Care Med 206:311\u2013320","journal-title":"Am J Respir Crit Care Med"},{"key":"6390_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.acra.2018.04.024","volume":"26","author":"G Santyr","year":"2018","unstructured":"Santyr G, Kanhere N, Morgado F et al (2018) Hyperpolarized gas magnetic resonance imaging of pediatric cystic fibrosis lung disease. Acad Radiol 26:344\u2013354","journal-title":"Acad Radiol"},{"key":"6390_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jcf.2016.07.008","volume":"16","author":"RP Thomen","year":"2016","unstructured":"Thomen RP, Walkup LL, Roach DJ et al (2016) Hyperpolarized 129Xe for investigation of mild cystic fibrosis lung disease in pediatric patients. J Cyst Fibros 16:275\u2013282","journal-title":"J Cyst Fibros"},{"issue":"5","key":"6390_CR9","doi-asserted-by":"publisher","first-page":"1802188","DOI":"10.1183\/13993003.02188-2018","volume":"53","author":"JH Rayment","year":"2019","unstructured":"Rayment JH, Couch MJ, McDonald N et al (2019) Hyperpolarised 129Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis. Eur Respir J 53(5):1802188. https:\/\/doi.org\/10.1183\/13993003.02188-2018","journal-title":"Eur Respir J"},{"key":"6390_CR10","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1016\/S1569-1993(22)00856-6","volume":"21","author":"L Walkup","year":"2022","unstructured":"Walkup L, Roach D, Zanette B et al (2022) Hyperpolarized xenon gas ventilation magnetic resonance imaging detects lung ventilation improvement in children with cystic fibrosis treated with elexacaftor\/tezacaftor\/ivacFaftor in a multisite study. J Cyst Fibros 21:S97","journal-title":"J Cyst Fibros"},{"key":"6390_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/mrm.22031","volume":"62","author":"G Bauman","year":"2009","unstructured":"Bauman G, Puderbach M, Deimling M et al (2009) Non-contrast-enhanced perfusion and ventilation assessment of the human lung by means of Fourier decomposition in proton MRI. Magn Reson Med 62:656\u2013664","journal-title":"Magn Reson Med"},{"key":"6390_CR12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/nbm.3134","volume":"27","author":"A Fischer","year":"2014","unstructured":"Fischer A, Weick S, Ritter CO et al (2014) Self-gated non-contrast-enhanced functional lung imaging (SENCEFUL) using a quasi-random fast low-angle shot (FLASH) sequence and proton MRI. NMR Biomed 27:907\u2013917","journal-title":"NMR Biomed"},{"key":"6390_CR13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/mrm.26096","volume":"77","author":"G Bauman","year":"2016","unstructured":"Bauman G, Bieri O (2016) Matrix pencil decomposition of time-resolved proton MRI for robust and improved assessment of pulmonary ventilation and perfusion. Magn Reson Med 77:336\u2013342","journal-title":"Magn Reson Med"},{"key":"6390_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/mrm.29656","volume":"90","author":"E Ilicak","year":"2023","unstructured":"Ilicak E, Ozdemir S, Zapp J et al (2023) Dynamic mode decomposition of dynamic MRI for assessment of pulmonary ventilation and perfusion. Magn Reson Med 90:761\u2013769","journal-title":"Magn Reson Med"},{"key":"6390_CR15","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1002\/mrm.26893","volume":"79","author":"A Voskrebenzev","year":"2018","unstructured":"Voskrebenzev A, Gutberlet M, Klime\u0161 F et al (2018) Feasibility of quantitative regional ventilation and perfusion mapping with phase-resolved functional lung (PREFUL) MRI in healthy volunteers and COPD, CTEPH, and CF patients. Magn Reson Med 79:2306\u20132314","journal-title":"Magn Reson Med"},{"key":"6390_CR16","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1002\/mrm.29566","volume":"89","author":"S Munidasa","year":"2022","unstructured":"Munidasa S, Zanette B, Couch M et al (2022) Inter- and intravisit repeatability of free-breathing MRI in pediatric cystic fibrosis lung disease. Magn Reson Med 89:2048\u20132061","journal-title":"Magn Reson Med"},{"issue":"4","key":"6390_CR17","doi-asserted-by":"publisher","first-page":"2003104","DOI":"10.1183\/13993003.03104-2020","volume":"57","author":"S Munidasa","year":"2021","unstructured":"Munidasa S, Couch MJ, Rayment JH et al (2021) Free-breathing MRI for monitoring ventilation changes following antibiotic treatment of pulmonary exacerbations in paediatric cystic fibrosis. Eur Respir J 57(4):2003104. https:\/\/doi.org\/10.1183\/13993003.03104-2020","journal-title":"Eur Respir J"},{"key":"6390_CR18","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/j.acra.2020.05.008","volume":"28","author":"MJ Couch","year":"2020","unstructured":"Couch MJ, Munidasa S, Rayment JH et al (2020) Comparison of functional free-breathing pulmonary 1H and hyperpolarized 129Xe magnetic resonance imaging in pediatric cystic fibrosis. Acad Radiol 28:e209\u2013e218","journal-title":"Acad Radiol"},{"key":"6390_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/mrm.30299","volume":"93","author":"S Munidasa","year":"2024","unstructured":"Munidasa S, Zanette B, Dumas MP et al (2024) Comparison of 3D UTE free-breathing lung MRI with hyperpolarized 129Xe MRI in pediatric cystic fibrosis. Magn Reson Med 93:775\u2013787","journal-title":"Magn Reson Med"},{"key":"6390_CR20","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/mrm.30416","volume":"93","author":"F Klime\u0161","year":"2025","unstructured":"Klime\u0161 F, Plummer JW, Willmering MM et al (2025) Quantifying spatial and dynamic lung abnormalities with 3D PREFUL FLORET UTE imaging: a feasibility study. Magn Reson Med 93:1984\u20131998","journal-title":"Magn Reson Med"},{"key":"6390_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00330-023-09912-6","volume":"34","author":"F Klime\u0161","year":"2024","unstructured":"Klime\u0161 F, Voskrebenzev A, Gutberlet M et al (2024) Effect of CFTR modulator therapy with elexacaftor\/tezacaftor\/ivacaftor on pulmonary ventilation derived by 3D phase-resolved functional lung MRI in cystic fibrosis patients. Eur Radiol 34:80\u201389","journal-title":"Eur Radiol"},{"key":"6390_CR22","doi-asserted-by":"publisher","first-page":"e230104","DOI":"10.1148\/ryct.230104","volume":"6","author":"M Dohna","year":"2024","unstructured":"Dohna M, Voskrebenzev A, Klime\u0161 F et al (2024) PREFUL MRI for monitoring perfusion and ventilation changes after elexacaftor-tezacaftor-ivacaftor therapy for cystic fibrosis: a feasibility study. Radiol Cardiothorac Imaging 6:e230104","journal-title":"Radiol Cardiothorac Imaging"},{"key":"6390_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319\u2013338","journal-title":"Eur Respir J"},{"key":"6390_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1183\/09031936.00069712","volume":"41","author":"PD Robinson","year":"2013","unstructured":"Robinson PD, Latzin P, Verbanck S et al (2013) Consensus statement for inert gas washout measurement using multiple- and single-breath tests. Eur Respir J 41:507\u2013522","journal-title":"Eur Respir J"},{"key":"6390_CR25","doi-asserted-by":"publisher","unstructured":"Voskrebenzev A, Klime\u0161 F, Wacker F et al (2024) Phase-resolved functional lung MRI for pulmonary ventilation and perfusion (V\/Q) assessment. J Vis Exp 9(210). https:\/\/doi.org\/10.3791\/66380","DOI":"10.3791\/66380"},{"key":"6390_CR26","doi-asserted-by":"publisher","first-page":"e4088","DOI":"10.1002\/nbm.4088","volume":"32","author":"F Klime\u0161","year":"2019","unstructured":"Klime\u0161 F, Voskrebenzev A, Gutberlet M et al (2019) Free-breathing quantification of regional ventilation derived by phase-resolved functional lung (PREFUL) MRI. NMR Biomed 32:e4088","journal-title":"NMR Biomed"},{"key":"6390_CR27","doi-asserted-by":"publisher","first-page":"e12054","DOI":"10.1002\/pul2.12054","volume":"12","author":"L Behrendt","year":"2022","unstructured":"Behrendt L, Smith LJ, Voskrebenzev A et al (2022) A dual-center and dual-vendor comparison study of automated perfusion-weighted phase-resolved functional lung magnetic resonance imaging with dynamic contrast-enhanced magnetic resonance imaging in patients with cystic fibrosis. Pulm Circ 12:e12054","journal-title":"Pulm Circ"},{"key":"6390_CR28","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/jmri.27385","volume":"53","author":"GH P\u00f6hler","year":"2020","unstructured":"P\u00f6hler GH, Klime\u0161 F, Behrendt L et al (2020) Repeatability of phase-resolved functional lung (PREFUL)-MRI ventilation and perfusion parameters in healthy subjects and COPD patients. J Magn Reson Imaging 53:915\u2013927","journal-title":"J Magn Reson Imaging"},{"key":"6390_CR29","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/jmri.28165","volume":"55","author":"B Zanette","year":"2022","unstructured":"Zanette B, Schrauben EM, Munidasa S et al (2022) Clinical feasibility of structural and functional MRI in free-breathing neonates and infants. J Magn Reson Imaging 55:1696\u20131707","journal-title":"J Magn Reson Imaging"},{"key":"6390_CR30","doi-asserted-by":"publisher","first-page":"2101499","DOI":"10.1183\/13993003.01499-2021","volume":"60","author":"S Stanojevic","year":"2022","unstructured":"Stanojevic S, Kaminsky DA, Miller MR et al (2022) ERS\/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 60:2101499","journal-title":"Eur Respir J"},{"key":"6390_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1164\/rccm.202006-2433OC","volume":"203","author":"L Perrem","year":"2021","unstructured":"Perrem L, Stanojevic S, Shaw M et al (2021) Lung clearance index to track acute respiratory events in school-age children with cystic fibrosis. Am J Respir Crit Care Med 203:977\u2013986","journal-title":"Am J Respir Crit Care Med"},{"key":"6390_CR32","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/jmri.27452","volume":"53","author":"TF Kaireit","year":"2020","unstructured":"Kaireit TF, Kern A, Voskrebenzev A et al (2020) Flow volume loop and regional ventilation assessment using phase-resolved functional lung (PREFUL) MRI: comparison with 129Xe ventilation MRI and lung function testing. J Magn Reson Imaging 53:1092\u20131105","journal-title":"J Magn Reson Imaging"},{"key":"6390_CR33","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.3390\/jcm11206160","volume":"11","author":"JL Goralski","year":"2022","unstructured":"Goralski JL, Chung SH, Ceppe AS et al (2022) Dynamic perfluorinated gas MRI shows improved lung ventilation in people with cystic fibrosis after elexacaftor\/tezacaftor\/ivacaftor: an observational study. J Clin Med 11:6160","journal-title":"J Clin Med"},{"key":"6390_CR34","doi-asserted-by":"publisher","first-page":"110421","DOI":"10.1016\/j.ejrad.2022.110421","volume":"154","author":"R Bec","year":"2022","unstructured":"Bec R, Reynaud-Gaubert M, Arnaud F et al (2022) Chest computed tomography improvement in patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: early report. Eur J Radiol 154:110421","journal-title":"Eur J Radiol"},{"key":"6390_CR35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jcf.2022.12.012","volume":"22","author":"C Streibel","year":"2023","unstructured":"Streibel C, Willers CC, Pusterla O et al (2023) Effects of elexacaftor\/tezacaftor\/ivacaftor therapy in children with cystic fibrosis \u2013 a comprehensive assessment using lung clearance index, spirometry, and functional and structural lung MRI. J Cyst Fibros 22:615\u2013622","journal-title":"J Cyst Fibros"},{"key":"6390_CR36","first-page":"0","volume":"39","author":"JP Amoakon","year":"2024","unstructured":"Amoakon JP, Mylavarapu G, Amin RS et al (2024) Pulmonary vascular dysfunctions in cystic fibrosis. Physiol (Bethesda) 39:0","journal-title":"Physiol (Bethesda)"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-025-06390-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00247-025-06390-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-025-06390-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T23:02:13Z","timestamp":1765926133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00247-025-06390-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":36,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6390"],"URL":"https:\/\/doi.org\/10.1007\/s00247-025-06390-4","relation":{},"ISSN":["1432-1998"],"issn-type":[{"value":"1432-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}